Cargando…
Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic
Lung cancer is the single biggest cause of cancer death. The diagnostic pathway can be complex, including specialist cancer diagnostics that are not performed at every hospital. One such example is endobronchial ultrasound (EBUS), a day-case bronchoscopic procedure used for nodal staging and tissue...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340577/ https://www.ncbi.nlm.nih.gov/pubmed/35902134 http://dx.doi.org/10.1136/bmjresp-2022-001321 |
_version_ | 1784760434714214400 |
---|---|
author | Evison, Matthew Shackley, David Galligan-Dawson, Lisa |
author_facet | Evison, Matthew Shackley, David Galligan-Dawson, Lisa |
author_sort | Evison, Matthew |
collection | PubMed |
description | Lung cancer is the single biggest cause of cancer death. The diagnostic pathway can be complex, including specialist cancer diagnostics that are not performed at every hospital. One such example is endobronchial ultrasound (EBUS), a day-case bronchoscopic procedure used for nodal staging and tissue diagnosis. In this proof-of-concept pilot in Greater Manchester, we tested a novel digital EBUS booking platform. This platform was accessible across multiple acute care trusts and provided visibility of all available EBUS appointments, allowing referring teams to book directly into the appropriate slot. During a 6-month pilot, 193 EBUS procedures were booked through this new single-queue platform. The median waiting times reduced by 2 days from 9 to 7 days (22% reduction and saving approximately 386 days in total) and reduced variation in waiting times by 1 day from 5 to 4 days (20% reduction). 98% of patients who completed an experience of care survey felt the process was ‘very well’ or ‘well’ organised and 77% felt the most important factor in deciding where to have their EBUS was the earliest possible appointment regardless of travel. This proof-of-concept pilot has shown improvements in cancer waiting times with significant future potential in delivering specialist cancer diagnostics. |
format | Online Article Text |
id | pubmed-9340577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-93405772022-08-01 Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic Evison, Matthew Shackley, David Galligan-Dawson, Lisa BMJ Open Respir Res Perspective Lung cancer is the single biggest cause of cancer death. The diagnostic pathway can be complex, including specialist cancer diagnostics that are not performed at every hospital. One such example is endobronchial ultrasound (EBUS), a day-case bronchoscopic procedure used for nodal staging and tissue diagnosis. In this proof-of-concept pilot in Greater Manchester, we tested a novel digital EBUS booking platform. This platform was accessible across multiple acute care trusts and provided visibility of all available EBUS appointments, allowing referring teams to book directly into the appropriate slot. During a 6-month pilot, 193 EBUS procedures were booked through this new single-queue platform. The median waiting times reduced by 2 days from 9 to 7 days (22% reduction and saving approximately 386 days in total) and reduced variation in waiting times by 1 day from 5 to 4 days (20% reduction). 98% of patients who completed an experience of care survey felt the process was ‘very well’ or ‘well’ organised and 77% felt the most important factor in deciding where to have their EBUS was the earliest possible appointment regardless of travel. This proof-of-concept pilot has shown improvements in cancer waiting times with significant future potential in delivering specialist cancer diagnostics. BMJ Publishing Group 2022-07-28 /pmc/articles/PMC9340577/ /pubmed/35902134 http://dx.doi.org/10.1136/bmjresp-2022-001321 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Perspective Evison, Matthew Shackley, David Galligan-Dawson, Lisa Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic |
title | Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic |
title_full | Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic |
title_fullStr | Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic |
title_full_unstemmed | Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic |
title_short | Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemic |
title_sort | regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the covid-19 pandemic |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340577/ https://www.ncbi.nlm.nih.gov/pubmed/35902134 http://dx.doi.org/10.1136/bmjresp-2022-001321 |
work_keys_str_mv | AT evisonmatthew regionalsinglequeueschedulingplatformforspecialistdiagnosticsinthelungcancerpathwayacceleratingcancerrecoveryfromthecovid19pandemic AT shackleydavid regionalsinglequeueschedulingplatformforspecialistdiagnosticsinthelungcancerpathwayacceleratingcancerrecoveryfromthecovid19pandemic AT galligandawsonlisa regionalsinglequeueschedulingplatformforspecialistdiagnosticsinthelungcancerpathwayacceleratingcancerrecoveryfromthecovid19pandemic |